Pharmaceutical Companies; Patent Issued for Treatment of BDNF-Related Disorders Using Laquinimod (US...
Pharmaceutical Companies; Patent Issued for Treatment of BDNF-Related Disorders Using Laquinimod (USPTO 9585878)
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent by the inventor Hayardeny, Liat (Tel Aviv, IL), filed on August 9, 2010, was published online on March 7, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents.The following quote was obtained by the news editors from the back...
Alternative Titles
Full title
Pharmaceutical Companies; Patent Issued for Treatment of BDNF-Related Disorders Using Laquinimod (USPTO 9585878)
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1877908461
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1877908461
Other Identifiers
ISSN
1543-6608
E-ISSN
1543-6616
